First Time Loading...
I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 7 000 KRW 0.57% Market Closed
Updated: May 18, 2024
Section:
 

Relative Value

The Relative Value of one Isu Abxis Co Ltd stock under the Base Case scenario is 7 162.44 KRW. Compared to the current market price of 7 000 KRW, Isu Abxis Co Ltd is Undervalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
7 162.44 KRW
Undervaluation 2%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Valuation Multiples

4.5
P/S
P/S
Price to Sales
4.5
vs History
87
vs Industry
68
Median 3Y
5.5
Median 5Y
8
Industry
8.2
Forward
3.4
More Details
67.1
P/E
P/E
Price to Earnings
67.1
vs History
9
vs Industry
3
Median 3Y
-28.9
Median 5Y
-13.9
Industry
26.1
Forward
-29.7
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
0
Median 3Y
-68.5
Median 5Y
-21.6
Industry
24.8
More Details
6.8
P/FCFE
P/FCFE
Price to FCFE
6.8
vs History
20
vs Industry
10
Median 3Y
-9.1
Median 5Y
-8.2
Industry
23.4
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
66
vs Industry
31
Median 3Y
3.7
Median 5Y
3.6
Industry
2.6
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
90
vs Industry
66
Median 3Y
4.9
Median 5Y
8.1
Industry
7.4
Forward
2.1
More Details
4.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.2
vs History
90
vs Industry
60
Median 3Y
13.4
Median 5Y
19.7
Industry
9.1
More Details
16.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.5
vs History
0
vs Industry
7
Median 3Y
-42.7
Median 5Y
-21.5
Industry
4.6
Forward
9.1
More Details
38
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
38
vs History
0
vs Industry
3
Median 3Y
-22.2
Median 5Y
-13.5
Industry
4.4
Forward
15.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
0
Median 3Y
-52.8
Median 5Y
-20.5
Industry
6.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-21.5
Median 5Y
-14.5
Industry
3.8
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
80
vs Industry
51
Median 3Y
2.2
Median 5Y
2.5
Industry
4.9
More Details

Multiples Across Competitors

Competitors Multiples
Isu Abxis Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Isu Abxis Co Ltd
KOSDAQ:086890
242.3B KRW 4.5 67.1 16.5 38
US
Abbvie Inc
NYSE:ABBV
293.9B USD 5.4 61 13.2 20.1
US
Amgen Inc
NASDAQ:AMGN
167.5B USD 5.7 44.5 18.7 30.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.7B USD 11.6 31.7 25.7 26.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
108.2B USD 8.3 28.1 22.7 25.2
AU
CSL Ltd
ASX:CSL
135.3B AUD 6.4 36.6 22.1 27.4
US
Gilead Sciences Inc
NASDAQ:GILD
84.1B USD 3.1 173.7 7 9.2
US
Moderna Inc
NASDAQ:MRNA
50.7B USD 9.8 -8.5 -9.4 -8.3
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.5B USD 3.5 28.7 14.6 18.2
KR
Celltrion Inc
KRX:068270
39.7T KRW 18.2 74.1 45.3 62.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.